<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Affected members of 63 families with a variety of <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:hpo ids='HP_0003584'>late onset</z:hpo> <z:hpo ids='HP_0001251'>cerebellar ataxias</z:hpo> (ADCA), and 29 patients with similar phenotypes but no affected relatives, were investigated for the trinucleotide (CAG) repeat expansion described in Japanese families with <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>This disorder had previously been shown to map to the region of chromosome 14 which also contains a locus causing ADCA in French families, spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> 3 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> mutation was identified in nine families with ADCA type I, and a further family in which affected members had <z:hpo ids='HP_0001300'>parkinsonism</z:hpo>, <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo>, <z:hpo ids='HP_0001332'>dystonia</z:hpo>, and <z:hpo ids='HP_0001257'>spasticity</z:hpo>, but little evidence of <z:e sem="disease" ids="C0007760" disease_type="Disease or Syndrome" abbrv="">cerebellar disease</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Only one of the 10 families was British (the Drew family of Walworth); the others originated from India, Jamaica, Ghana, Brazil and France </plain></SENT>
<SENT sid="4" pm="."><plain>There was no single clinical feature which distinguished patients with the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> mutation from those with the CAG expansion on chromosome 6 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA1</z:e>) or ADCA type I families with no known mutation </plain></SENT>
<SENT sid="5" pm="."><plain>The CAG repeat length ranged from 13-41 copies on <z:mpath ids='MPATH_458'>normal</z:mpath> chromosomes and 62-80 copies on affected chromosomes </plain></SENT>
<SENT sid="6" pm="."><plain>There was a significant inverse correlation between <z:hpo ids='HP_0011007'>age of onset</z:hpo> of symptoms and repeat length, but no significant effect of parental sex on repeat length or <z:hpo ids='HP_0011007'>age of onset</z:hpo> in offspring </plain></SENT>
<SENT sid="7" pm="."><plain>DNA analysis for the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> mutation is useful for diagnosis in patients with familial ataxic or <z:hpo ids='HP_0002071'>extrapyramidal syndromes</z:hpo>, and will aid genetic counselling in these disorders </plain></SENT>
</text></document>